Donald J. Griffith - 15 Dec 2021 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role: Director
Signature: /s/ John Harry Cross III, power of attorney
Issuer symbol: SONN
Transactions as of: 15 Dec 2021
Net transactions value: -$1,655
Form type: 4
Filing time: 08 Apr 2022, 16:30:52 UTC
Previous filing: 28 May 2021
Next filing: 17 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SONN	Common Stock	Award		+15,000	+16%		110,693	15 Dec 2021	Direct	F1
transaction	SONN	Common Stock	Tax liability	$1,655	-4,507	-4.1%	$0.3673	106,186	08 Apr 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 15, 2021, the Reporting Person was granted 15,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2023.
F2	The price reported in Column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $0.3673 to $0.3800 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Content

On December 15, 2021, the Reporting Person was granted 15,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2023.

The price reported in Column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $0.3673 to $0.3800 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.